Peripheral Neuropathy: Independent Evidence on Nerve Pain Drugs
Causes, tests and the NICE drug ladder for nerve pain, with supplements graded, foot care in diabetes and who funded the evidence, including gabapentin’s 2004 plea.
Evidence-graded research on diabetes and blood-sugar control — what the systematic reviews and trials really show about diet, supplements and metabolic health.
Causes, tests and the NICE drug ladder for nerve pain, with supplements graded, foot care in diabetes and who funded the evidence, including gabapentin’s 2004 plea.
Cinnamon, chromium, alpha-lipoic acid, bitter melon and apple cider vinegar show weak or insufficient glucose benefits, with real risks from coumarin, ALA and acid.
CGMs like FreeStyle Libre and Dexcom are well supported for insulin users. We review accuracy, NICE eligibility, small type 2 benefits, recalls and the unproven wellness market.
Low-carb diets lower blood sugar faster than other diets for about six months, but the gap mostly closes by a year. What the independent evidence says, and who profits.
Insulin is essential in type 1 diabetes and powerful in type 2. Newer analogues cut hypos modestly but not HbA1c; three firms dominate a market whose US prices led to rationing.
Sitagliptin and other gliptins lower blood sugar modestly with few hypos and look heart-neutral, but they do not prevent heart attacks or deaths and carry rare pancreatitis and skin risks.
SGLT2 inhibitors cut heart-failure admissions and slow kidney disease, but every major trial was industry-funded and the drugs carry rare ketoacidosis and infection risks.
Tirzepatide causes large weight loss in Lilly-funded trials, but weight returns after stopping. We trace the evidence, the risks, NHS access and who profits.
Semaglutide (Ozempic, Wegovy, Rybelsus) causes large weight loss while taken, but weight returns on stopping; nearly all trials were funded by Novo Nordisk.
Gliclazide lowers blood sugar cheaply and looks heart-neutral in trials, but it causes more hypoglycaemia and weight gain than newer drugs and offers no proven heart benefit.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.